tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jonathan Demchick, 13 are a HOLD (65%), 4 are a BUY (20%), 3 are a SELL (15%).
Analyst Jonathan Demchick, carries an average stock price target met ratio of 90.91% that have a potential upside of 8.94% achieved within 298 days. Previously, Jonathan Demchick worked at MORGAN STANLEY.
Jonathan Demchick’s has documented 42 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on NUVA, NuVasive at 04-Aug-2023.
Analyst best performing recommendations are on NUVA (NUVASIVE).
The best stock recommendation documented was for NUVA (NUVASIVE) at 12/15/2020. The price target of $53 was fulfilled within 8 days with a profit of $7.13 (15.54%) receiving and performance score of 19.43.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 28-Jul-2026
$82
$7.81 (10.53%)
$85
1 months 17 days ago
(28-Jul-2026)
9/13 (69.23%)
$1.42 (1.76%)
366
Buy Since 18-Nov-2025
$100
$25.81 (34.79%)
$105
1 months 29 days ago
(16-Jul-2026)
33/35 (94.29%)
$19.09 (23.59%)
361
Buy Since 09-Dec-2021
$115
$40.81 (55.01%)
$120
2 months 1 days ago
(13-Jul-2026)
10/14 (71.43%)
$35.25 (44.20%)
111
Buy Since 06-Nov-2024
$100
$13.75 (15.94%)
$115
2 months 30 days ago
(15-Jun-2026)
22/25 (88%)
$22.68 (29.33%)
325
Buy Since 25-Feb-2026
$117
$30.75 (35.65%)
$114
4 months 6 days ago
(08-May-2026)
3/6 (50%)
$39.05 (50.10%)
499
